Prevalence of risk factors for venous thromboembolism: A case-control study on 150 patients hospitalised in internal medicine;Facteurs de risque de la maladie thromboembolique veineuse chez des malades hospitalisés en médecine interne: Une enquête cas-témoins sur 150 patients

Revue de Medecine Interne

Volumn 23, Issue 11, 2002, Pages 910-918

  Pottier, Pierre ^a   Planchon, B ^a   Pistorius, M A ^a   Grolleau, J Y ^a  

^a HÔTEL DIEU   (France)

Author keywords

Case control study; Internal medicine; Prevalence

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BED REST; BODY HEIGHT; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; POSTTHROMBOSIS SYNDROME; PREVALENCE; PROSPECTIVE STUDY; RISK ASSESSMENT; THROMBOGENESIS; VARICOSIS; VEIN INSUFFICIENCY; VEIN THROMBOSIS;

ACUTE DISEASE; AGE FACTORS; AGED; BED REST; CASE-CONTROL STUDIES; FEMALE; HUMANS; INCIDENCE; INPATIENTS; INTERNAL MEDICINE; MALE; MIDDLE AGED; OBESITY; PARALYSIS; RISK FACTORS; THROMBOEMBOLISM;

EID: 17944397627     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(02)00686-0     Document Type: Article

References (28)

1. Consensus Conference. Prevention of venous thrombosis and pulmonary embolism. JAMA 1986;256:744-9.
2. Thromboembolic Risk factor (THRIFT) Consensus Group. Risk of and prophylaxis for venous thromboembolism in hospital patients. Br Med J 1992;305:567-74.
3. Consensus Statement. Prevention of venous thromboembolism. Int Angiol 1997;16:3-38.
4. Hirsh J, Dalen J, Guyatt G. American College of Chest Physicians. The sixth (2000) ACCP guidelines for antithrombotic therapy prevention and treatment of thrombosis. American College of Chest Physicians. Chest 2001;119:1-2 (1 Suppl).
5. Mc Carthy ST, Turner J. Low-dose subcutaneous heparin in the prevention of deep-vein thrombosis and pulmonary emboli following acute stroke. Age Ageing 1986;15:84-8.
6. Turpie AGG, Hirsh J. Double-blind randomized trial of ORG 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke. Lancet 1987;3:523-6.
7. Prerovski I, Niederle P, Simonova J, Kapitola J. Deep vein thrombosis and its prevention in patients with acute myocardial infarction. Cor Vasa 1988:345-51.
8. Benoist M, Barrelier MT, Gautier P. La maladie thrombo-embolique veineuse en milieu gériatrique. Intéret de son dépistage et de son traitement. J Mal Vasc 1994;19:289-93.
9. Dahan R, Houlbert D, Caulin C, Cuzin E, Viltart C, Woler M, et al. Prevention of deep vein thrombosis in elderly medical in-patients by a low molecular weight heparin: A randomized double-blind trial. Haemostasis 1986;16:159-64.
10. Bick RL, Jakway J, Baker WF. Deep vein thrombosis: Prevalence of etiologic factors and results of management in 100 consecutive patients. Semin Thromb Hemostasis 1992;18:267-74.
11. Hirsch DR, Ingenito EP, Goldhaber SZ. Prevalence of deep venous thrombosis among patients in medical intensive care. JAMA 1995;274:335-7.
12. Kniffin WD, Baron JA, Barret J, Birkmeyer JD, Anderson FA. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med 1994;154:816-61.
13. Quinn AD, Thomson BT, Terrin ML, Thrall JH, Athanasoulis CA, Mc Kusick KA, et al. A prospective investigation of pulmonary embolism in women and men. JAMA 1992;268:1686-96.
14. Anderson FA JR, Wheeler HB, Goldberg RJ. The prevalence of risk factors for venous thromboembolism among hospital patients. Arch Intern Med 1992;152:1660-4.
15. Arcellus JI, Candocia S, Traverso CI, Fabrega F, Caprini JA, Hasty JH. Venous thromboembolism prophylaxis and risk assessment in medical patients. Semin Thromb Hemostasis 1991;17:313-8.
16. Bergmann JF, Mahe I. Prevention of deep venous thrombosis in medical patients. Ann Med Interne 2000;151:207-14.
17. White RH, Zhou H, Romano PS. Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann Intern Med 1998;128:737-40.
18. Cogo A, Bernardi E, Prandoni P, Girolami B, Noventa F, Simioni P, et al. Acquired risk factors for deep vein thrombosis in symptomatic outpatients. Arch Intern Med 1994;154:164-8.
19. Kearon C, Gent M, Hirsh J, Weitz J, Kovacs MJ, Anderson DR. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 1999;340:901-7.
20. Harenberg J, Kallenbach B, Martin U, Dempfle CE, Zimmermann R, Kubler W, et al. Randomized controlled study of heparin and low molecular weight heparin for prevention of deep-vein thrombosis in medical patients. Thromb Res 1990;59:639-50.
21. Lechler E, Schramm W, Flosbach CW. The PRIME study group. The venous thrombotic risk in non-surgical patients: Epidemiological data and efficacy/safety profile of a low-molecular-weight heparin (enoxaparin). Haemostasis 1996;26(suppl 2):49-56.
22. Samama MM, Cohen AT, Darmon JY, Desjardins L, Eldor A, Janbon C, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. N Engl J Med 1999;341:793-800.
23. Pottier P, Planchon B, Truchaud F, Pistorius MA, Furic I, Grolleau JY. Rationalisation des facteurs de risque de la maladie thrombo-embolique veineuse en milieu médical polyvalent hospitalier: Une étude prospective. J Mal Vasc 2000;25:241-9.
24. Pottier P, Planchon B, Pistorius MA, Grolleau JY. Facteurs de risque et incidence de la maladie thrombo-embolique veineuse en médecine interne: Une étude descriptive prospective sur 947 patients hospitalisés. Rev Med Interne 2001;22:348-59.
25. Ninet J, Horrellou MH, Darjinof JJ, Caulin C, Leizorovicz. Evaluation des facteurs de risque préopératoires. Ann Fr Anesth Réanim 1992;11:252-81.
26. Coon WW. Epidemiology of venous thromboembolism. Am Surg 1977;186:149-64.
27. Janssen HJ, Schachner J, Hubbard J, Hartman JT. The risk of deep vein thrombosis a computerized epidemiologic approach. Surgery 1986;101:205-12.
28. Giauffret F, Pottier P, Pistorius MA, Planchon B. Thromboses veineuses des membres inférieurs et cancer. Evaluation des facteurs de risque de thrombose veineuse en milieu médical. J Mal Vasc 1997;22:234-8.